# Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

> **NCT05018793** · PHASE1 · RECRUITING · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 15 (estimated)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **BIOLOGICAL:** autologous adipose derived mesenchymal stem cells
- **BIOLOGICAL:** AlloRx

## Key facts

- **NCT ID:** NCT05018793
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018793, "Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05018793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*